- Report
- October 2024
- 186 Pages
Global
From €3237EUR$3,545USD£2,747GBP
€3596EUR$3,939USD£3,052GBP
- Report
- October 2024
- 192 Pages
Global
From €3237EUR$3,545USD£2,747GBP
€3596EUR$3,939USD£3,052GBP
- Report
- October 2024
- 193 Pages
Global
From €3237EUR$3,545USD£2,747GBP
€3596EUR$3,939USD£3,052GBP
- Report
- February 2025
- 240 Pages
Global
From €2456EUR$2,690USD£2,085GBP
- Report
- March 2025
- 200 Pages
Global
From €4100EUR$4,490USD£3,479GBP
- Report
- May 2025
- 184 Pages
Global
From €5341EUR$5,850USD£4,533GBP
- Report
- May 2025
- 380 Pages
Global
From €5341EUR$5,850USD£4,533GBP
- Report
- January 2025
- 135 Pages
Global
From €2738EUR$2,999USD£2,324GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1141EUR$1,250USD£969GBP
- Report
- August 2024
- 233 Pages
Global
From €7259EUR$7,950USD£6,161GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1370EUR$1,500USD£1,162GBP
- Report
- February 2025
- 60 Pages
Global
From €9126EUR$9,995USD£7,745GBP
- Report
- September 2024
- 150 Pages
Europe
From €3150EUR$3,450USD£2,673GBP
- Report
- May 2024
- 136 Pages
Global
From €5934EUR$6,499USD£5,036GBP
- Report
- May 2024
- 128 Pages
Global
From €5934EUR$6,499USD£5,036GBP
- Report
- January 2024
- 395 Pages
Global
From €6848EUR$7,500USD£5,812GBP
- Report
- April 2023
- 147 Pages
Global
From €4519EUR$4,949USD£3,835GBP
- Report
- August 2022
- 111 Pages
Global
From €4337EUR$4,750USD£3,681GBP
- Report
- February 2024
- 120 Pages
Global
From €4337EUR$4,750USD£3,681GBP
- Report
- April 2023
- 120 Pages
Global
From €4337EUR$4,750USD£3,681GBP
Valproate is a drug used to treat a variety of neurological disorders, including epilepsy, bipolar disorder, and migraine headaches. It is a type of anticonvulsant, meaning it works to reduce the frequency and severity of seizures. Valproate is also used to treat mania and depression, as well as to prevent migraine headaches. Valproate is available in both oral and intravenous forms, and is often prescribed in combination with other medications.
Valproate is a widely used drug in the Central Nervous System (CNS) drug market. It is used to treat a variety of neurological disorders, including epilepsy, bipolar disorder, and migraine headaches. Valproate is also used to treat mania and depression, as well as to prevent migraine headaches. Valproate is available in both oral and intravenous forms, and is often prescribed in combination with other medications.
Some companies in the Valproate market include AbbVie, GlaxoSmithKline, Johnson & Johnson, Pfizer, and Sanofi. Show Less Read more
